title: Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?
abstract: Anemia of chronic kidney disease (CKD) is common and is associated with diminished quality of life, cognitive impairment, cardiovascular morbidity, hospitalizations, and mortality. As the prevalence of end-stage renal disease continues to rise, the management of anemia represents a growing economic burden. Erythropoiesis-stimulating agents (ESA) are the mainstay of anemia management but their use is limited due to the associated cardiovascular adverse events. Prolyl hydroxylase domain enzyme (PHD) inhibitors are a new class of drugs that stabilize the hypoxia-inducible factors and are under clinical investigation for the treatment of renal anemia. The advantages of PHD inhibitors include the oral route of administration, improved iron profile, restoration of diurnal rhythm of erythropoietin secretion, and endogenous erythropoietin production near physiological range. Emerging but limited data indicates a small blood pressure lowering effect of PHD inhibitors. The effect of PHD inhibitors on cardiovascular endpoints and the potential risks of CKD progression and pulmonary hypertension remains to be addressed in the ongoing clinical trials.
authors.affiliation: Division of Nephrology, NewYork-Presbyterian/Queens, 56-45 Main Street, Flushing, New York, NY, 11355, USA. fay9005@nyp.org.
authors.forename: Farhanah
authors.initials: F
authors.lastname: Yousaf
authors.affiliation: Division of Nephrology, NewYork-Presbyterian/Queens, 56-45 Main Street, Flushing, New York, NY, 11355, USA.
authors.forename: Bruce
authors.initials: B
authors.lastname: Spinowitz
mesh_terms: D000818:Animals; D051792:Basic Helix-Loop-Helix Proteins / Q000378:metabolism*; D001794:Blood Pressure; D006454:Hemoglobins / Q000378:metabolism*; D006706:Homeostasis; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D051793:Hypoxia-Inducible Factor 1 / Q000378:metabolism*; D051436:Renal Insufficiency, Chronic / Q000150:complications; D000099162:Endothelial PAS Domain-Containing Protein 1
chemical_list: D051792:Basic Helix-Loop-Helix Proteins; D006454:Hemoglobins; D051793:Hypoxia-Inducible Factor 1; D000099162:Endothelial PAS Domain-Containing Protein 1
keywords: Anemia; Erythropoietin; HIF-1α; HIF-2 α; Hypertension; Hypoxia-inducible factor; Iron; Nitric oxide; PHD inhibitors; Prolyl-hydroxylase domain; Pulmonary hypertension